원격 환자 모니터링 시장 : 업계 동향과 세계 예측 - 소프트웨어 유형별, 용도별, 치료 영역별, 제품/소프트웨어 목적별, 비즈니스 모델별, 주요 지역별

REMOTE PATIENT MONITORING MARKET: OVERVIEW

As per Roots Analysis, the global remote patient monitoring market is estimated to grow from USD 9.4 billion in the current year to USD 88.0 billion by 2035, at a CAGR of 25% during the forecast period, till 2035.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Software

• System as a Software
• System as a Service

Application Area

• Blood Glucose
• Blood Pressure
• Body Temperature
• Electrocardiogram
• Oxygen Saturation
• Respiration Rate
• Others

Therapeutic Area

• Cardiovascular Disorders
• Infectious Diseases
• Metabolic Disorders
• Oncological Disorders
• Respiratory Disorders
• Others

Product / Software Purpose

• Commercial Purpose
• Clinical Purpose

Type of Business Model

• B2B
• B2C

Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• Middle East and North Africa
• Latin America

REMOTE PATIENT MONITORING MARKET: GROWTH AND TRENDS

Over the years, the incidence of chronic conditions, such as diabetes, autoimmune diseases, heart diseases, and cancer has risen significantly. In fact, a recent report from the Center for Managing Chronic Disease at the University of Michigan reported that over 50% of the US population is affected by some form of chronic disease. Consequently, there is an urgent need for frequent monitoring to manage disease indications. However, some patients fail to report health issues to healthcare providers in time, which can lead to severe consequences and increased healthcare costs. In this context, remote patient monitoring has emerged as a potential solution for healthcare providers that enables them to monitor vital health signs in home care settings.

The initiation of the concept of remote patient monitoring system (RPM) started nearly 200 years ago in 1800s. However, it wasn't until the introduction of cloud computing that the domain evolved at a significant pace. In fact, remote patient monitoring system solutions were gradually integrated into mainstream healthcare, specifically during the COVID-19 induced lockdown. These advanced tools and software solutions enabled and eased monitoring of patient health significantly during that period. These advanced devices utilize AI and biosensors to monitor vital signs like oxygen levels, blood pressure, heart rate, respiratory rate, blood glucose level, and other key signs in real time. Presently, several companies are focused on the development of remote patient monitoring systems.

REMOTE PATIENT MONITORING MARKET: KEY INSIGHTS

The report delves into the current state of the remote patient monitoring market and identifies potential growth opportunities within industry. Some key findings from the report include:

• At present, more than 170 players claim to have the required capabilities to offer remote patient monitoring solutions for use across a range of application areas.
• Tools / software solutions for remote patient monitoring are being investigated across different types of software and are designed to target different therapeutic areas.

• In order to gain a competitive edge, remote patient monitoring solution developers are actively undertaking initiatives to integrate advanced features in their respective solutions and affiliated offerings.
• Over the years, industry players have established several deals to further advance the development / enable the improvement of their proprietary software solutions.
• To support the ongoing innovation in this field, private and public investors have made substantial capital investments of worth USD 2.5 billion.
• Given the favourable increase in demand for various remote patient monitoring solutions during the COVID-19 pandemic, the overall market is poised to grow at a CAGR of over 25%, till 2030.

• The projected opportunity is expected to be well distributed across different areas of application, types of business model and key geographical regions.

REMOTE PATIENT MONITORING MARKET: KEY SEGMENTS

System as a Software Segment holds the Largest Share of the Remote Patient Monitoring Market

Based on the type of software, the market is segmented into a system as a software and system as a service type of software. At present, the system as a software segment holds the maximum share of the global remote patient monitoring market. Further, the remote patient monitoring market for system as a service segment is expected to show the highest market growth potential during the forecast period owing to the growing demand for cloud-based solutions.

By Application Area, Electrocardiogram is the Fastest Growing Segment of the Global Remote Patient Monitoring Market

Based on the application area, the market is segmented into blood glucose, blood pressure, body temperature, electrocardiogram, oxygen saturation, respiration rate and others. At present, the electrocardiogram segment holds the maximum share of the global remote patient monitoring market. This can be attributed to the growing prevalence of cardiovascular disorders that require constant monitoring of vital health parameters. Moreover, the market for electrocardiogram segment is expected to grow at a higher CAGR during the forecast period.

By Therapeutic Area, Metabolic Disorders Segment Accounts for the Largest Share of the Global Remote Patient Monitoring Market

Based on the therapeutic area, the market is segmented into cardiovascular disorders, infectious diseases, metabolic disorders, oncological disorders, respiratory disorders, and others. Currently, the metabolic disorders segment captures the highest proportion of the global remote patient monitoring market. However, the oncological disorders segment is expected to grow at a higher CAGR during the forecast period.

By Product / Software Purpose, Commercial Purpose Segment is Likely to Dominate the Remote Patient Monitoring Market

Based on the product / software purpose, the market is segmented into commercial purpose and clinical purpose. At present, the commercial purpose segment holds the maximum share of the remote patient monitoring market. However, the clinical purpose segment is expected to show the highest growth potential during the forecast period, growing at a higher CAGR, compared to the other segments.

B2C is the Fastest Growing Segment of the Global Remote Patient Monitoring Market

Based on the type of business model, the global market is segmented into B2C and B2B models. Currently, both B2C and B2B segments hold equal market share. However, the remote patient monitoring for B2C segment is expected to witness substantial growth in the coming years.

Europe Accounts for the Largest Share of the Market

Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. Currently, Europe dominates the global remote patient monitoring market and accounts for the largest revenue share. Further, the market in Asia-Pacific is likely to grow at a higher CAGR in the coming future.

Example Players in the Remote Patient Monitoring Market

• BioTelemetry
• Braster
• LeewayHertz
• LifeWatch
• Masimo
• Medtronic
• Siemens Healthineers
• Transtek Medical.

REMOTE PATIENT MONITORING MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the global remote patient monitoring market, focusing on key market segments, including [A] type of software, [B] application area, [C] therapeutic area, [D] product / software purpose, [E] type of business model and [F] key geographical regions.
• Market Landscape: A comprehensive evaluation of the companies engaged in providing remote patient monitoring consultation tools and software, based on several relevant parameters, such as [A] year of establishment, [B] company size and [C] location of headquarters. Additionally, a comprehensive evaluation of consultation tools and software, based on several relevant parameters, such as [A] type of software, [B] area of application, [C] therapeutic areas, [D] product / software purpose, [E] type of telemedicine operation, [F] type of remote patient monitoring service and [G] type of business model.
• Company Profiles: In-depth profiles of key players that are engaged in the development of remote patient monitoring software, focusing on [A] overview of the company, [B] financial information (if available), [C] product portfolio and [D] recent developments and an informed future outlook.
• Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in the remote patient monitoring market, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of partner, [D] type of software, [E] most active players and [F] geographical distribution of the partnership activity.
• Funding and Investments: An in-depth analysis of the fundings raised by remote patient monitoring companies, based on relevant parameters, such as [A] year of funding instances, [B] amount invested, [C] type of funding, [D] geographical analysis, [E] most active players and [F] most active investors.
• Product Competitiveness Analysis: A comprehensive competitive analysis of remote patient monitoring software, examining factors, such as [A] supplier power and [B] key product-related specifications.
• Cost Saving Analysis: A comprehensive analysis of cost saving potential associated with the use of remote patient monitoring consultation tools and software solutions, examining factors, such as [A] number of patient visits and [B] increase in efficiency by adoption of remote patient monitoring software solutions.
• Case Study: An insightful discussion on how the COVID-19 pandemic impacted the remote patient monitoring software market, accompanied by information on the important initiatives that were undertaken by players to overcome the challenges faced due to the pandemic.
• SWOT Analysis: An analysis of industry affiliated trends, opportunities and challenges, which are likely to impact the evolution of remote patient monitoring market; it includes a Harvey ball analysis, assessing the relative impact of each SWOT parameter on industry dynamics.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
  • 1.2.1. Research Assumptions
  • 1.2.2. Project Methodology
  • 1.2.3. Forecast Methodology
  • 1.2.4. Robust Quality Control
  • 1.2.5. Key Considerations
    • 1.2.5.1. Demographics
    • 1.2.5.2. Economic Factors
    • 1.2.5.3. Government Regulations
    • 1.2.5.4. Supply Chain
    • 1.2.5.5. COVID Impact / Related Factors
    • 1.2.5.6. Market Access
    • 1.2.5.7. Healthcare Policies
    • 1.2.5.8. Industry Consolidation
• 1.3 Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Introduction to Telemedicine
  • 3.2.1. Store-and-Forward Telemedicine
  • 3.2.2. Real-Time Telemedicine
  • 3.2.3. Telemedicine in Remote Patient Monitoring
• 3.3. Advantages of Remote Patient Monitoring
• 3.4. Limitations Associated with Remote Patient Monitoring
• 3.5. Regulatory Considerations for Remote Patient Monitoring Solutions
• 3.6. Concluding Remarks

4. MARKET LANDSCAPE

• 4.1. Chapter Overview
• 4.2. Remote Patient Monitoring Consultation Tools and Software: Overall Market Landscape
  • 4.2.1. Analysis by Type of Software
  • 4.2.2. Analysis by Purpose of Software
  • 4.2.3. Analysis by Area of Application
  • 4.2.4. Analysis by Therapeutic Area
  • 4.2.5. Analysis by Type of Telemedicine Operation
  • 4.2.6. Analysis by Type of Remote Patient Monitoring Service Offered
  • 4.2.7. Analysis by Type of Business Model
• 4.3. Remote Patient Monitoring Consultation Tools and Software: Solution Providers Landscape
  • 4.3.1. Analysis by Year of Establishment
  • 4.3.2. Analysis by Company Size
  • 4.3.3. Analysis by Location of Headquarters

5. COMPANY PROFILES

• 5.1. Chapter Overview
• 5.2. Players based in North America
  • 5.2.1. BioTelemetry
    • 5.2.1.1. Company Overview
    • 5.2.1.2. Financial Information
    • 5.2.1.3. Software Portfolio
    • 5.2.1.4. Future Outlook
  • 5.2.2. LeewayHertz
    • 5.2.2.1. Company Overview
    • 5.2.2.2. Software Portfolio
    • 5.2.2.3. Future Outlook
  • 5.2.3. Masimo
    • 5.2.3.1. Company Overview
    • 5.2.3.2. Financial Information
    • 5.2.3.3. Software Portfolio
    • 5.2.3.4. Future Outlook
• 5.3. Players based in Europe
  • 5.3.1. Braster
    • 5.3.1.1. Company Overview
    • 5.3.1.2. Software Portfolio
    • 5.3.1.3. Future Outlook
  • 5.3.2. LifeWatch
    • 5.3.2.1. Company Overview
    • 5.3.2.2. Software Portfolio
    • 5.3.2.3. Future Outlook
  • 5.3.3. Medtronic
    • 5.3.3.1. Company Overview
    • 5.3.3.2. Financial Information
    • 5.3.3.3. Software Portfolio
    • 5.3.3.4. Future Outlook
  • 5.3.4. Siemens Healthineers
    • 5.3.4.1. Company Overview
    • 5.3.4.2. Financial Information
    • 5.3.4.3. Software Portfolio
    • 5.3.4.4. Future Outlook
• 5.4. Players based in Asia-Pacific
  • 5.4.1. Transtek Medical
    • 5.4.1.1. Company Overview
    • 5.4.1.2. Financial Information
    • 5.4.1.3. Software Portfolio
    • 5.4.1.4. Future Outlook

6. PARTNERSHIPS AND COLLABORATIONS

• 6.1. Chapter Overview
• 6.2. Partnership Models
• 6.3. Remote Patient Monitoring Consultation Tools and Software Providers: Recent Partnerships and Collaborations
  • 6.3.1. Analysis by Year of Partnership
  • 6.3.2. Analysis by Type of Partnership
    • 6.3.2.1. Analysis by Year and Type of Partnership
    • 6.3.2.2. Analysis by Type of Partnership and Company Size
  • 6.3.3. Analysis by Type of Software
    • 6.3.3.1. Analysis by Year of Partnership and Type of Software
    • 6.3.3.2. Analysis by Type of Partnership and Type of Software
  • 6.3.4. Most Active Players: Analysis by Number of Partnerships
  • 6.3.5. Regional Analysis
    • 6.3.5.1. Intercontinental and Intracontinental Agreements

7. FUNDING AND INVESTMENT ANALYSIS

• 7.1. Chapter Overview
• 7.2. Types of Funding
• 7.3. Remote Patient Monitoring Consultation Tools and Software Providers: Funding and Investment Analysis
  • 7.3.1. Analysis by Cumulative Year-wise Trend, Since 2015
  • 7.3.2. Analysis by Amount Invested
  • 7.3.3. Analysis by Type of Funding
    • 7.3.3.1. Analysis by Type of Venture Capital Round
  • 7.3.4. Analysis by Type of Software
  • 7.3.5. Analysis by Focus Area
  • 7.3.6. Analysis by Geography
  • 7.3.7. Most Active Players: Analysis by Number of Instances
  • 7.3.8. Most Active Players: Analysis by Amount Invested
  • 7.3.9. Most Active Investors: Analysis by Number of Instances
  • 7.3.10. Analysis by Year, Amount Invested and Type of Investor
• 7.4. Concluding Remarks

8. PRODUCT COMPETITIVENESS ANALYSIS

• 8.1. Chapter Overview
• 8.2. Methodology
• 8.3. Assumptions / Key Parameters
• 8.4. Product Competitiveness: Software as a Service
• 8.5. Product Competitiveness: Software as a System

9. COST SAVING ANALYSIS

• 9.1. Chapter Overview
• 9.2. Key Assumptions and Methodology
• 9.3. Remote Patient Monitoring Solutions: Overall Cost Saving Potential
  • 9.3.1. Likely Cost Savings in North America, Till 2035
  • 9.3.2. Likely Cost Savings in Europe, Till 2035
  • 9.3.3. Likely Cost Savings in Asia, Till 2035
  • 9.3.4. Likely Cost Savings in Rest of the World, Till 2035
• 9.4. Conclusion

10. MARKET FORECAST

• 10.1. Chapter Overview
• 10.2. Forecast Methodology and Key Assumptions
• 10.3. Global Remote Patient Monitoring Consultation Tools and Software Providers Market, Till 2035
• 10.4. Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Area of Application
  • 10.4.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Glucose, Till 2035
  • 10.4.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Pressure, Till 2035
  • 10.4.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for ECG, Till 2035
  • 10.4.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oxygen Saturation, Till 2035
  • 10.4.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiration Rate, Till 2035
  • 10.4.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Body Temperature, Till 2035
  • 10.4.7. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Areas of Application, Till 2035
• 10.5. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Therapeutic Area
  • 10.5.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Cardiovascular Disorders, Till 2035
  • 10.5.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Infectious Diseases, Till 2035
  • 10.5.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for Metabolic Disorders, Till 2035
  • 10.5.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oncological Disorders, Till 2035
  • 10.5.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiratory Disorders, Till 2035
  • 10.5.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Therapeutic Areas, Till 2035
• 10.6. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Purpose of Software
  • 10.6.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Clinical Studies, Till 2035
  • 10.6.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Commercial Purposes, Till 2035
• 10.7. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Business Model
  • 10.7.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2B, Till 2035
  • 10.7.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2C, Till 2035
• 10.8. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Geography
  • 10.8.1. Remote Patient Monitoring Consultation Tools and Software Providers Market in North America, Till 2035
  • 10.8.2. Remote Patient Monitoring Consultation Tools and Software Providers Market in Europe, Till 2035
  • 10.8.3. Remote Patient Monitoring Consultation Tools and Software Providers Market in Asia-Pacific, Till 2035
  • 10.8.4. Remote Patient Monitoring Consultation Tools and Software Providers Market in Middle East and North Africa (MENA), Till 2035
  • 10.8.5. Remote Patient Monitoring Consultation Tools and Software Providers Market in Latin America, Till 2035

11. IMPACT OF COVID-19 PANDEMIC ON DIGITAL SOLUTIONS FOR BIOMARKERS MARKET

• 11.1. Chapter Overview
• 11.2. Impact of COVID-19 on Telemedicine and Remote Patient Monitoring
  • 11.2.1. Impact on Future Market Opportunity for Remote Patient Monitoring
• 11.3. Recuperative Initiatives of Key Players
• 11.4. Recuperative Strategies for Businesses
  • 11.4.1. Strategies for Implementation in the Short / Mid Term
  • 11.4.2. Strategies for Implementation in the Long Term

12. SWOT ANALYSIS

• 12.1. Chapter Overview
• 12.2. Strengths
• 12.3. Weaknesses
• 12.4. Opportunities
• 12.5. Threats
• 12.6. Comparison of SWOT Factors

13. CONCLUSION

14. INTERVIEW TRANSCRIPTS

• 14.1. Chapter Overview
• 14.2. Company A
  • 14.2.1. Company Snapshot
  • 14.2.2. Survey Transcript

15. APPENDIX I: TABULATED DATA

16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS